The estimated Net Worth of Thomas P Koestler is at least $818 Mille dollars as of 19 June 2019. Thomas Koestler owns over 4,356 units of Momenta Pharmaceuticals stock worth over $818,163 and over the last 14 years Thomas sold MNTA stock worth over $0.
Thomas has made over 2 trades of the Momenta Pharmaceuticals stock since 2018, according to the Form 4 filled with the SEC. Most recently Thomas exercised 4,356 units of MNTA stock worth $228,603 on 19 June 2019.
The largest trade Thomas's ever made was exercising 5,734 units of Momenta Pharmaceuticals stock on 20 June 2018 worth over $300,920. On average, Thomas trades about 841 units every 30 days since 2011. As of 19 June 2019 Thomas still owns at least 15,590 units of Momenta Pharmaceuticals stock.
You can see the complete history of Thomas Koestler stock trades at the bottom of the page.
Thomas's mailing address filed with the SEC is C/O MOMENTA PHARMACEUTICALS, INC., 301 BINNEY STREET, CAMBRIDGE, MA, 02172.
Over the last 20 years, insiders at Momenta Pharmaceuticals have traded over $110,027,424 worth of Momenta Pharmaceuticals stock and bought 827,300 units worth $5,505,611 . The most active insiders traders include Christoph H Westphal, Craig A Wheeler e Peter Barrett. On average, Momenta Pharmaceuticals executives and independent directors trade stock every 6 days with the average trade being worth of $448,442. The most recent stock trade was executed by Ian Fier on 20 August 2020, trading 1,808 units of MNTA stock currently worth $94,323.
Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.
Momenta Pharmaceuticals executives and other stock owners filed with the SEC include: